SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000875045-21-000032
Filing Date
2021-06-08
Accepted
2021-06-08 16:18:45
Documents
14
Period of Report
2021-06-02
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K biib-20210602.htm   iXBRL 8-K 85361
2 EX-3.1 formxex31xcertificateofame.htm EX-3.1 9448
  Complete submission text file 0000875045-21-000032.txt   297280

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT biib-20210602.xsd EX-101.SCH 2293
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT biib-20210602_lab.xml EX-101.LAB 25282
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT biib-20210602_pre.xml EX-101.PRE 25377
6 EXTRACTED XBRL INSTANCE DOCUMENT biib-20210602_htm.xml XML 11002
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 211002377
SIC: 2836 Biological Products, (No Diagnostic Substances)